FDA Approves Pomalyst for Advanced Multiple Myeloma
The US Food and Drug Administration today approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease progressed after being treated with other cancer drugs.
Finding the Path of No Return for Kids with Cancer
The cure rate for one type of blood cancer that affects children - acute lymphoblastic leukemia (ALL) – is now about 80 percent. For the remaining 20 percent of kids who develop the disease, the outlook can be dire.
New Rx for Advanced Multiple Myeloma
Multiple myeloma is a blood cancer that affects nearly 22,000 Americans every year. It develops in mostly older people when plasma cells in the bone marrow grow out of control.
Paradigm Shift - Healthy vs. Cancerous Cells
If you focus on maintaining a healthy lifestyle, you’re less likely to get sick. That’s simple logic. Researchers now think this approach might be an effective way to treat cancer.
A Combination Leukemia Can’t Take
Many patients with chronic lymphocytic leukemia do pretty well with standard treatment. The disease retreats and stays in remission. However, some patients aren’t so fortunate. A new combination may be just what these patients need.
Children With Leukemia Have New Rx
Acute lymphoblastic leukemia (ALL) is the most common blood cancer found in children. It’s diagnosed in nearly 3,000 children in the United States every year and can progress quickly if left untreated. These kids now have a new treatment option.
FDA Approves Gleevec for Children With Acute Lymphoblastic Leukemia
The US Food and Drug Administration today approved a new use of Gleevec ( imatinib ) to treat children newly diagnosed with Philadelphia chromosome positive ( Ph +) acute lymphoblastic leukemia (ALL).
Cancer Trends Nobody’s Talking About
The cancer statistical bibles have been released this year. The American Cancer Society focused on the outstanding news – that cancer deaths declined 20 percent between 1991 and 2009. What wasn’t mentioned is the rising number of different types of cancers and increasing numbers of deaths estimated for this year – 2013.
New Vaccine Recommendation for Adults
Adults with certain immune system conditions often require different recommendations for the vaccines they can and should receive. A new vaccine has been added to these recommendations.
Age Matters When Treating Leukemia
Unless a child is involved, age usually isn’t considered when prescribing cancer treatment. A new study finds that might need to be changed for certain leukemia patients.